Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Zitonggong Pharmaceutical is a historic Chinese pharmaceutical company with roots tracing back to 1780, holding the prestigious China Time-honored Brand designation. The company specializes in the research, manufacturing, and commercialization of chemical drugs and Traditional Chinese Medicines (TCM), with a particular focus on neurology, respiratory, and digestive health. Its flagship product, Citicoline Sodium Tablets (marketed as Yishenghua), is a market leader in China for treating neurological deficits associated with stroke and traumatic brain injury. Listed on the Beijing Stock Exchange, the company operates integrated R&D and manufacturing facilities in Sichuan. Zitonggong continues to expand its portfolio through both internal development and strategic acquisitions in the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 四川梓橦宫.